BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
+0.71%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$197M
AUM Growth
+$197M
(-21%)
Cap. Flow
-$52.9M
Cap. Flow
% of AUM
-26.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
InflaRx
IFRX
|
$27.7M |
| 2 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$25.2M |
Sector Composition
| 1 | Healthcare | 30.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $115M | 58.64% | 7,330,237 -1,600,000 | -18% | -$25.2M |
|
2
Replimune Group
REPL
$422M
| $41.6M | 21.14% | 2,838,968 | – | – |
|
|
MRNS
3
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $20.9M | 10.63% | 5,042,735 | – | – |
|
4
Solid Biosciences
SLDB
$427M
| $11.4M | 5.81% | 1,989,444 | – | – |
|
|
APTX
5
DELISTED
Aptinyx Inc. Common Stock
APTX
| $7.43M | 3.78% | 2,225,092 | – | – |
|
|
6
InflaRx
IFRX
$108M
| – | – | -732,670 | Closed | -$27.7M |
|